Objectives: To apply a systems pathology-based approach to the quantification of nuclear Active β-catenin and human leukocyte antigen class I, and assess the biomarker involvement in a cohort of prostate tumor patients. Results: The systems pathology approach applied allows a precise quantification of the marker expression in the different cell compartments as well as the determination of the areas that coexpress two markers. Our data shows that the accumulation of β-catenin in the nuclear compartment is significantly decreased in the adjacent normal areas when compared to tumor of the same patients (p < 0.001). In conclusion, the application of this novel multiple immunofluorescence assay demonstrates that the upregulation of Active β-catenin is a relatively common feature of prostate tumor development, and further supports the activation of the Wnt/β-catenin pathway in prostate cancer progression.
CITATION STYLE
Puig, P., Erill, N., Terricabras, M., Subirana, I., González-García, J., Asensi-Puig, A., … González-Rumayor, V. (2019). Multiple immunofluorescence assay identifies upregulation of Active β-catenin in prostate cancer. BMC Research Notes, 12(1). https://doi.org/10.1186/s13104-019-4100-z
Mendeley helps you to discover research relevant for your work.